Table II.
Relationship between lncRNA-XIST expression level (∆Ct) and clinicopathological characteristics of the PC patients.
| lncRNA-XIST | |||
|---|---|---|---|
| Characteristics | n (%) | Mean ± SD | P-value |
| Total no. of patients | 139 | ||
| Age (years) | 0.101 | ||
| >60 | 59 (42.4) | 11.85±1.73 | |
| ≤60 | 80 (57.6) | 11.19±2.69 | |
| Sex | 0.232 | ||
| Male | 89 (64.0) | 11.59±1.75 | |
| Female | 50 (36.0) | 12.02±2.45 | |
| Lymphatic metastasis | 0.235 | ||
| N0 | 94 (67.6) | 12.05±1.49 | |
| N1-N2 | 45 (32.4) | 11.71±1.73 | |
| Distal metastasis | 0.003b | ||
| M0 | 105 (75.5) | 11.98±1.06 | |
| M1 | 34 (24.5) | 11.14±2.16 | |
| TNM stage | 0.012a | ||
| 0, I, II | 91 (65.5) | 11.72±1.58 | |
| III, IV | 48 (34.5) | 10.96±1.83 |
a
P<0.05
b
P<0.01. PC, pancreatic cancer; lncRNA, long non-coding RNA; XIST, X inactive-specific transcript; TNM, tumor-node-metastasis.